26 June 2020 : Clinical Research
Hepatitis B Surface Antigen (HBsAg) Kinetics in Chronic Hepatitis B Patients during Peginterferon Treatment
Kaifa Wang1AEG, Guangyu Huang2BCF*, Yagang Chen2DF, Yuming Wang34BFDOI: 10.12659/MSM.921487
Med Sci Monit 2020; 26:e921487
Table 7 Information of 13 new functionally cured patients.
| ID | Gender | Age (years) | Baseline HBsAg (IU/mL) | Treatment duration (days) | Pattern |
|---|---|---|---|---|---|
| 379951 | Male | 32 | 32.08 | 196 | 1 |
| 34472 | Male | 43 | 77.87 | 168 | 1 |
| 69976 | Male | 30 | 31.7 | 195 | 1 |
| 292154 | Male | 32 | 13.42 | 98 | 1 |
| 517077 | Male | 31 | 23.9 | 90 | 1 |
| 417389 | Male | 40 | 30.26 | 133 | 1 |
| 75165 | Male | 43 | 224.36 | 251 | 1 |
| 19196 | Female | 31 | 623.58 | 149 | 1 |
| 91684 | Male | 44 | 788.63 | 251 | 3 |
| 130152 | Male | 41 | 1.43 | 216 | 3 |
| 198746 | Male | 46 | 2.16 | 167 | 4 |
| 414897 | Male | 37 | 11.02 | 140 | 4 |
| 17603 | Male | 29 | 22.43 | 210 | 5 |